Table 1.
Chiral CE methods for the analysis of pharmaceuticals developed by using experimental design strategies.
| Analytes | Sample | Experimental Design Type | Factors | Responses | Optimized Conditions | References |
|---|---|---|---|---|---|---|
| Clenbuterol | bulk substance | PBD | BGE pH, BGE concentration, CD concentration, methanol concentration, injection time | resolution, migration time, number of theoretical plates | 0.1 M citric acid/0.2 M phosphate BGE, pH 4.0, 16 mM β-CD, 19 °C, 13 kV, 214 nm | [47] |
| Amlodipine | bulk substance | CCD | BGE pH, CD concentration, temperature | resolution, Kaiser peak separation function | 50 mM phosphate BGE, pH 3.16, 18.2 mM α-CD, 17.2 °C, 25 kV, 214 nm | [48] |
| Dexfenfluramine-chiral purity (levofenfluramine) | bulk substance | PBD | BGE pH, CD concentration, methanol concentration, temperature, voltage | resolution, migration time, peak symmetry | 100 mM phosphate BGE, pH 3.0, 10 mM DM-β-CD, 40% methanol, 20 °C, 25 kV, 214 nm | [50] |
| Amphetamines (amphetamine, methamphetamine, MDA, MDMA, MDEA) | bulk substance | CCD | BGE concentration, BGE pH, CD concentration, temperature, voltage | amphetamine resolution, total resolution, migration time, generated power | 118 mM phosphate BGE, pH 3.5, 16 mM HP-β-CD, 28 °C, 25 kV, 200 nm | [51] |
| Epinephrine | bulk substance | FrFD CCD |
BGE concentration, BGE pH, CD concentration, temperature, voltage BGE concentration, CD concentration, voltage |
resolution, migration time | 111 mM phosphate BGE, pH 7.0, 9 mM CM-β-CD, 20 °C, 18 kV, 206 nm | [52] |
| Imidazole derivatives (bifonazole, econazole, miconazole, sulconazole) | bulk substance | FrFD | BGE pH, acetonitrile concentration, CD concentration, temperature | resolution, migration time, number of theoretical plates | 100 mM phosphate BGE, pH 4.70, 5.2% acetonitrile, 5.80 mM β-CD, 35 °C, 30 kV, 230 nm | [53] |
| Celiprolol | bulk substance, tablet, urine | FCCD | BGE concentration, BGE pH, CD concentration, temperature | resolution, migration time, current | 52 mM acetate BGE, pH 4.0, 3 mM S-β-CD, 19.5 °C, 30 kV, 220 nm | [55] |
| Salbutamol | spiked urine | PBD DD |
BGE concentration, BGE pH, CS concentration, methanol concentration, voltage BGE pH, CS concentration, voltage |
resolution, migration time | 30 mM Tris BGE, pH 5.3, 1.75% dermatan sulphate, 5% methanol, 15 °C, 24 kV, 220 nm | [59] |
| Atropine | ophthalmic solution, plant extract | CCD | BGE concentration, BGE pH, CD concentration | resolution, migration time, current | 55 mM phosphate BGE, pH 7.0, 2.9 mM S-β-CD, 20 °C, 20 kV, 195 nm | [60] |
| Methadone | bulk substance | FFD FCCD |
CD concentration, percentage of capillary filled with CD, gas nebulization pressure | resolution | CE-ESI-MS: 20 mM ammonium acetate BGE, pH 4.0, 18 mg/mL HP-β-CD/ 0.25 mg/mL CM-β-CD/ 0.4 mg/mL SBE-β-CD, 90/70/90% capillary-filled, nebulization pressure 2 psi | [110] |
| Lactic acid | body fluids (plasma, urine, amniotic and cerebrospinal fluid) | FFD FFD |
BGE concentration, BGE pH, CS concentration BGE concentration, CS concentration |
resolution | 200 mM phosphate BGE, pH 6.0, 413 mM HP-β-CD, 20 °C,−20 kV, 200 nm | [63] |
| Propranolol | bulk substance | FCCD | BGE concentration, BGE pH, acetonitrile concentration | effective mobility, efficiency, symmetry, selectivity, relative mobility difference, resolution, difference in effective mobility | 15 mM bistris-acetate, pH 6.5, 31.2 µM Cel7A, 17% (v/v) acetonitrile, 22 °C, 20 µA, 200 nm | [64] |
| 2-[(4′-benzoyloxy-2′-hydroxy)phenyl-propionic acid] | bulk substance | CCD | CS concentration, BGE pH, temperature | resolution, migration time | 50 mM Britton-Robinson BGE, pH 6.4, 7 mM vancomycin, 22 °C, 20 kV, 195 nm | [65] |
| Ofloxacin | bulk substance | FCCD | BGE concentration, BGE pH, CD concentration, temperature | resolution, migration time, peak area, current | 50 mM phosphate BGE, pH 2.8, 4% (w/v) M-β-CD, 25 °C, 20 kV, 280 nm | [66] |
| Ketamine | injection solution | PBD CCD |
BGE concentration, BGE pH, CD concentration, methanol concentration, voltage BGE pH, methanol concentration |
resolution | 50 mM phosphate BGE, pH 5.20, 2% (w/v) CM-β-CD, 30% methanol, 20 °C, 15 kV, 206 nm | [67] |
| Tamsulosin | bulk substance | BBD FCCD CCC |
CD concentration, voltage, temperature | resolution, migration time | 100 mM Tris BGE, pH 2.5, 0.15% (w/v) S-β-CD, 25 °C, 25 kV, 210 nm | [75] |
| Risperidone, 9-hydroxyrisperidone | bulk substance | CCD | CD1 concentration, CD2 concentration, BGE concentration | resolution, migration time, selectivity, number of theoretical plates | 80 mM phosphate BGE, pH 2.5, 37 mM HP- β-CD, 3.7% S-α-CD, 25 °C, 20 kV, 270 nm | [76] |
| S-Citalopram--chiral purity (R-Citalopram) | bulk substance, tablets | FCCD | BGE concentration, CD2 concentration, voltage, temperature | resolution, migration time, current | 20 mM phosphate BGE, pH 2.5, 0.5 mg/mL β-CD, 22 mg/mL S-α-CD, 28 °C, −20 kV, 205 nm | [77] |
| Propranolol, 4-hydroxypropranolol | bulk substance | BBD | BGE concentration, BGE pH, CD concentration, voltage | resolution, migration time | 25 mM triethylamine/phosphate BGE, pH 9.0, 4% (w/v) CM-β-CD, 25 °C, 17 kV, 208 nm | [78] |
| Zopiclone | bulk substance, tablets | FFD | BGE concentration, BGE pH, CD concentration, voltage | resolution, migration time | 60.2 mM phosphate BGE, pH 2.0, 1 M urea, 20 mM β-CD, 25 °C, 30 kV, 215 nm | [79] |
| Clopidogrel (chiral purity R-clopidogrel) | bulk substance | reduced CCD | BGE concentration, BGE pH, CD concentration, voltage | resolution, migration time | 10 mM triethylamine–phosphoric acid BGE, pH 2.3, 5% S-β-CD, 20 °C, −12 kV, 195 nm | [80] |
| Dapoxetine | bulk substance | OAD | BGE concentration, BGE pH, CD concentration, methanol concentration, temperature, voltage | resolution | 70 mM acetate BGE, pH 4.5, 3 mM M-γ-CD, 20% (v/v) methanol, 15 °C, 15 kV, 215 nm | [82] |
| Magnesium-L-aspartate (chiral purity D-aspartate) | bulk substance, tablets | FFD | BGE concentration, BGE pH, CD concentration | resolution, migration time | 50 mM phosphate, pH 7, 18 mM HP-β-CD, 18% (v/v) DMSO, 20 °C, 30 kV, LIF detection | [87] |
| Asenapine | bulk substance | OAD | BGE concentration, BGE pH, CD concentration, methanol concentration, temperature, voltage | resolution | 160 mM Tris-acetate BGE, pH 3.5, 7 mM β-CD, 20 °C, 15 kV, 214 nm | [89] |
| Pomalidomide | bulk substance | OAD | BGE concentration, BGE pH, temperature, voltage | resolution | 50 mM Tris-acetate BGE, pH 6.5, 15 mM CM-β-CD, 20 °C, 15 kV, 215 nm | [90] |
| Lenalidomide (chiral purity R-lenalidomide) | bulk substance | FCCD | BGE concentration, temperature, voltage | resolution | 30 mM phosphate BGE, pH 6.5, 30 mM SBE-β-CD, 10 °C, 12 kV, 210 nm | [91] |
| Vildagliptin (chiral purity R-vildagliptin) | bulk substance, tablets | OAD | BGE concentration, BGE pH, CD concentration, temperature, voltage, injection parameters | resolution | 75 mM Tris-acetate BGE, pH 4.75, 20 mM SBE-α-CD, 15 °C, 25 kV, 40 mbar × 4 s hydrodynamic injection, 200 nm | [92] |
| Levosulpiride, (chiral purity R-sulpiride) | bulk substance, tablets | Asymmetric screening matrix DD |
BGE concentration, BGE pH, type of neutral cyclodextrin, charged CD concentration, neutral CD concentration, voltage BGE pH, charged CD concentration, neutral CD concentration, voltage |
resolution, migration time | 5 mM Britton-Robinson BGE, pH 3.45, 10 mM S-β-CD, 34 mM M-β-CD, 16 °C, −14 kV, 214 nm | [88] |
| Ambrisentan (chiral purity R-ambrisentan) | bulk substance, coated tablets | Asymmetric screening matrix FCCD |
BGE concentration, BGE pH, CD concentration, SDS concentration, temperature, voltage, capillary length BGE pH, CD concentration, voltage |
resolution, migration time | capillary total length 64.5 cm, 100 mM borate BGE, pH 9.20, 100 mM SDS, 50 mM γ-CD, 22 °C, 30 kV, 200 nm | [112] |
| S-Ambrisentan (chiral purity R-ambrisentan) | bulk substance | FrFD FCCD |
concentration, BGE pH, CD concentration, temperature, voltage BGE concentration, temperature, voltage |
resolution, migration time | 50 mM sodium acetate BGE, pH 4.0, 30 mM γ-CD, 25 °C, 25 kV, 200 nm | [93] |
| Montelukast (chiral purity R-trans-montelukast, R,S-cis-montelukast, S,R-cis-montelukast) | bulk substance, chewable tablets, oral granules | FFD | BGE concentration, voltage | resolution | 20 mM borate BGE, 10 mM SDS, pH 9.0, 10 mM HTM-β-CD, 12 mM SBE-β-CD, 15 °C, 18 kV, 254 nm | [113] |
| Levomepromazine (chiral purity R-mepromazine) | bulk substance, injection solution | FrFD FCCD |
BGE concentration, BGE pH, CD concentration, temperature, voltage BGE concentration, BGE pH, CD concentration |
resolution, migration time, selectivity | 100 mM citric acid BGE, pH 2.85, 3.6 mg/mL HP-γ-CD, 15 °C, 25 kV, 253 nm | [114] |
| S-Dapoxetine (chiral purity R-Dapoxetine) | bulk substance, tablets | FrFD FCCD |
BGE concentra-tion, BGE pH, CD1-CD2 1:1 mix concentration, temperature, voltage CD1 concentra-tion, CD2 concentration, voltage |
resolution, migration time, peak symmetry, current | 50 mM phosphate BGE, pH 6.3, 45 mg/mL S-γ-CD, 40.2 mg/mL DM-β-CD, 15 °C, 9 kV, 215 nm | [83] |
| Sitafloxacin, chiral impurities | bulk substance | FrFD FCCD |
BGE concentration, BGE pH, CD concentration, Cu2+ concentration, D-Phe concentration, temperature, voltage BGE pH, CD concentration, Cu2+ concentration, D-Phe concentration |
resolution, migration time | 15 mM phosphate BGE, pH 4.5, 15 mM D-Phe, 20 mM CuSO4, 20 mM γ-CD, 25 °C, 15 kV, 297 nm | [94] |
| Fluoxetine | bulk substance, tablets | OAD | BGE concentration, BGE pH, CD concentration, temperature, voltage, injection parameters | resolution | 50 mM phosphate BGE, pH 5.0, 10 mM HTM-β-CD, 15 °C, 20 kV, 50 mbar × 1 s hydrodynamic injection, 230 nm | [95] |
| Pregabalin | bulk substance, capsules | D-oD FCCD |
BGE concentration, BGE pH, CD concentration, temperature, voltage CD concentration, temperature, voltage |
resolution, migration time | 100 mM phosphate BGE concentration, pH 2.5, 40 mg/mL HTM-β-CD, 25 °C, 15 kV, 220 nm | [96] |
| Dexmedetomidine (chiral purity R-medetomidine) | bulk substance, tablets | FrFD FCCD |
BGE concentration, BGE pH, CD concentration, temperature, voltage CD concentration, temperature, voltage |
selectivity, migration time, current | 50 mM phosphate BGE, pH 6.5, 40 mg/mL S-β-CD, 17 °C, 10 kV, 200 nm | [97] |
| Dextrometorphan (chiral purity R-metorphan) | bulk substance, tablets | FrFD FCCD |
BGE concentration, BGE pH, CD concentration, temperature, voltage CD concentration, voltage |
resolution, migration time | 30 mM phosphate BGE, pH 6.5, 16 mg/mL S-β-CD, 14 mg/mL M-α-CD, 20 °C, 20 kV, 200 nm | [98] |
| Cinacalcet (chiral purity S-cinacalcet) | bulk substance, tablets | BBD | BGE pH, CD concentration, methanol concentration, voltage | resolution, migration time | 150 mM phosphate BGE, pH 2.7, 3.1 mM HP-γ-CD, 2% (v/v) methanol, 18 °C, 26 kV, 220 nm | [99] |
| Benzodiazepines (lorazepam, lormetazepam, oxazepam, temazepam) | bulk substance | FrFD | BGE pH, CD type, CD concentration, methanol concentration | resolution | 20 mM borate BGE, pH 9.0, 5% HES-β-CD, 15% methanol, 15 °C, 20 kV, 230 nm | [100] |
| Lansoprazole, Rabeprazole | bulk substance, capsules | FrFD CCD |
BGE concentration, BGE pH, CD1 concentration, temperature, voltage CD1 concentration, voltage, temperature |
resolution, migration time | Lansoprazole: 25 mM phosphate BGE, pH 7.0, 10 mM SBE-β-CD, 20 mM γ-CD, 17 °C, 20 kV, 210 nm Rabeprazole: 25 mM phosphate BGE, pH 7.0, 15 mM SBE-β-CD, 30 mM γ-CD, 18 °C, 20 kV, 210 nm | [104] |
| Levodropropizine (chiral purity R-dropropizine) | bulk substance, pharmaceutical drops | FFD FCCD |
CD concentration, temperature, voltage, 2-propanol concentration CD concentration, temperature |
separation factors, migration time, current | 25 mM phosphate BGE, pH 7.0, 23.5 mg/mL S-β-CD, 10% (v/v) 2-propanol, 16.3 °C, 16.5 kV, 200 nm | [106] |
| Levomepromazine (chiral purity R-mepromazine) | bulk substance, tablets | FrFD FCCD |
BGE concentration, CD concentration, temperature, voltage BGE concentration, CD concentration, temperature |
resolution, migration time, current | 750 mM acetic acid, 55 mM ammonium acetate in methanol BGE, 27.5 mg/mL HDMS-β-CD, 15 °C, 22 kV, 250 nm | [120] |
| Tramadol | bulk substance, capsules | FCCD | BGE pH, CD concentration, temperature | resolution, migration time | 25 mM tetraborate BGE, pH 11.0, 5 mM CM-β-CD, 15 °C, 17.5 kV, 210 nm | [105] |
| Amlodipine | bulk substance, tablets | OAD | BGE concentration, BGE pH, CD concentration, temperature, voltage, injection parameters | resolution | 25 mM phosphate BGE, pH 9.0, 15 mM CM-β-CD, 15 °C, 25 kV, 30 mbar × 1 s hydrodynamic injection, 230 nm | [107] |
| Citalopram | bulk substance, tablets | FrFD FCCD |
BGE concentration, BGE pH, CD concentration, temperature, voltage, injection pressure CD concentration, temperature, voltage |
resolution, migration time | 25 mM phosphate BGE, pH 7.0, 3 mM CM-β-CD, 17.5 °C, 15 kV, 50 mbar injection pressure, 230 nm | [108] |
| Venlafaxine | bulk substance, capsules | FCCD | CD concentration, temperature, voltage | resolution, migration time | 25 mM phosphate BGE, pH 2.5, 10 mM CM-β-CD, 15 °C, 25 kV, 230 nm | [109] |